Levocetirizine La Colina

Levocetirizine dihydrochloride, the active ingredient in Levocetirizine La Colina, is a second‑generation antihistamine presented as an oral dosage form for oral use. It is indicated for the relief of symptoms associated with allergic rhinitis and chronic idiopathic urticaria in adults and children.

GNH USA supplies Levocetirizine La Colina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocetirizine acts on histamine‑mediated allergic pathways, providing relief in common IgE‑driven conditions. - Allergic rhinitis: reduces nasal congestion, sneezing, itching and rhinorrhea. - Chronic idiopathic urticaria: alleviates hives and associated itching, improving quality of life.

Levocetirizine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate pain often reported. - Drowsiness: occasional sleepiness, especially at treatment initiation. - Dry mouth: reduced salivation leading to oral discomfort. - Fatigue: feeling of reduced energy. - Altered taste: transient metallic or bitter sensation.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips or tongue requiring urgent care. - Anaphylaxis: severe allergic reaction with respiratory compromise. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Cardiac arrhythmia: rare cases of irregular heartbeat reported.

Before using Levocetirizine, consider the following safety measures. - Renal impairment: dose adjustment may be required in patients with reduced kidney function. - Hypersensitivity: avoid if known allergy to levocetirizine or other piperazine antihistamines. - Alcohol and CNS depressants: use with caution as additive sedation may occur. - Elderly patients: monitor for increased drowsiness or confusion. - Pregnancy and breastfeeding: safety not established; consult a healthcare professional. - Store below 25°C: keep in the original pack, protect from moisture.

Levocetirizine may interact with other medicines; review the following categories.

Major Interactions (Avoid): - Other sedating antihistamines: combined use can cause excessive drowsiness. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase levocetirizine plasma levels.

Moderate Interactions (Monitor Closely): - Alcohol: can enhance central nervous system depression. - CNS depressants (e.g., benzodiazepines, opioids): may increase sedation. - Theophylline: may require monitoring of respiratory status. - Ritonavir: may modestly raise levocetirizine concentrations. - Anticholinergic drugs: may exacerbate dry mouth.